期刊文献+

雷贝拉唑联合多潘立酮治疗FD的临床研究 被引量:1

Effect of Rabeprazole Combined with Domperidone on Functional Dyspepsia
在线阅读 下载PDF
导出
摘要 目的:评价雷贝拉唑联合多潘立酮治疗功能性消化不良(FD)的临床疗效。方法:雷贝拉唑联合多潘立酮治疗FD患者30例,为治疗组;单用多潘立酮治疗FD患者30例,为对照组。结果:治疗组与对照组的总有效率分别为86.7%和43.3%(P<0.05)。两组患者治疗后均未发现不良反应。结论:雷贝拉唑联合多潘立酮能有效缓解FD的症状,是治疗FD安全、有效的方法。 Objective To investigate the effect of rabeprazole combined with domperidone on functional dyspepsia (FD). Methods Rabeprazole combined with domperidone were used in 30 cases(treated group), 30 cases were given domperidone only(controlled group), Results The total effective rates of the treated group and the controlled group were 86. 7% and 43. 3% (P〈0. 05), respectively, No side effects were found in 2 groups. Conclusions Rabeprazole combined with domperidone could improve symptoms inpatients with FD and have excellent therapeutic effects on the FD patients.
出处 《实用医技杂志》 2005年第09B期2502-2503,共2页 Journal of Practical Medical Techniques
关键词 功能性消化不良 雷贝拉唑 多潘立酮 临床试验 Functional dyspepsia Rabeprazole Domperidone Clinical trail
作者简介 袁如彩(1969-),女,江苏徐州人,2004年毕业于徐州医学院,主管药剂师。
  • 相关文献

参考文献4

二级参考文献38

  • 1[2]Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia:double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther, 1998, 12: 1055~1065.
  • 2[3]Blum AL, Arnold R, Stolte M, Fischer M, Koelz HR. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Gut, 2000, 47: 473~480.
  • 3[1]Huber R, Kohl B, Sachs G, et al. The continuing development of proton pump inhibitors with particular reference to pantorazole [J]. Aliment Pharmacol Ther , 1995,9:363.
  • 4[2]Blum RA.Lansoprazol and omeprazol in the treatment of acid peptic disorders[J]. Am J Health-Syst Pharm , 1996,53:1401.
  • 5[3]Chiverton SG, Howden CW, Burget DW, et al. Omeprazole (20 mg)daily given in the morning or evening: a comparison of effects on gastric acidity,and plasma gastrin and omeprazole concentration[J] .Aliment Pharmacol Ther,1992,6:103.
  • 6[4]Savarino V, Mela GS, Zentilin P, et al. Variability in individual response to various doses of omeprazole: implication for anti-unlcertherapy[J]. Dig Dis Sci, 1994,39(1):161.
  • 7[5]Bergatrand R.Decreased oral bioavialability of lansoprazole in healthy clunteeres when given with a standardized breakfast[J]. Clin Drug Invest, 1995,9:67.
  • 8[6]Katz PO, Anderson C, Khoury R, et al, Gastro-esophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors[J]. Aliment Pharmacol Ther , 1998,12:1231.
  • 9[7]Ishizaki T, Horai Y.Cytochrome P450 and the metabolism of proton pump inhibitors-emphasis on rabeprazole [J] . Aliment PharmacolTher, 1999,13 (Suppl 3) :27.
  • 10[8]Dammann HG, Burkhardt F. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion[J]. Eur J GastroenterolHepatol, 1999,11:1277.

共引文献249

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部